Cargando…

A content review of buprenorphine training programs for pharmacists

OBJECTIVES: To identify and describe continuing education (CE) credit-bearing training programs for pharmacists that cover buprenorphine dispensing. METHODS: Five CE databases were searched for trainings that were in English, targeted to pharmacists, addressed use of buprenorphine for opioid use dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Scott A., Dryer, Robyn, Zule, William, Ostrach, Bayla, Carpenter, Delesha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256820/
https://www.ncbi.nlm.nih.gov/pubmed/35813287
http://dx.doi.org/10.1016/j.rcsop.2022.100154
_version_ 1784741205111734272
author Davis, Scott A.
Dryer, Robyn
Zule, William
Ostrach, Bayla
Carpenter, Delesha M.
author_facet Davis, Scott A.
Dryer, Robyn
Zule, William
Ostrach, Bayla
Carpenter, Delesha M.
author_sort Davis, Scott A.
collection PubMed
description OBJECTIVES: To identify and describe continuing education (CE) credit-bearing training programs for pharmacists that cover buprenorphine dispensing. METHODS: Five CE databases were searched for trainings that were in English, targeted to pharmacists, addressed use of buprenorphine for opioid use disorder treatment, not state-specific, accredited by the Accreditation Council for Pharmacy Education, and available for online registration. RESULTS: Twelve trainings met the inclusion criteria. The most common topics covered were background and statistical information (10 trainings) and the clinical role of buprenorphine in medication assisted therapy (9 trainings). No training covered all 10 topics assessed. Seven programs included content on prescribing barriers, but of those, only two briefly addressed buprenorphine dispensing barriers, and none addressed the widespread belief that the Drug Enforcement Administration sets limits on the amount of buprenorphine that can be ordered and stocked. A majority of the programs (75%) addressed the clinical details of treatment, but only five addressed social barriers, such as stigma. CONCLUSION: Future trainings should develop and increase pharmacists' awareness of content to address the gaps identified in this study so they can supplement existing trainings, especially related to DEA and wholesaler regulations and thresholds, communication, stigma, and ways of overcoming these.
format Online
Article
Text
id pubmed-9256820
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92568202022-07-07 A content review of buprenorphine training programs for pharmacists Davis, Scott A. Dryer, Robyn Zule, William Ostrach, Bayla Carpenter, Delesha M. Explor Res Clin Soc Pharm Article OBJECTIVES: To identify and describe continuing education (CE) credit-bearing training programs for pharmacists that cover buprenorphine dispensing. METHODS: Five CE databases were searched for trainings that were in English, targeted to pharmacists, addressed use of buprenorphine for opioid use disorder treatment, not state-specific, accredited by the Accreditation Council for Pharmacy Education, and available for online registration. RESULTS: Twelve trainings met the inclusion criteria. The most common topics covered were background and statistical information (10 trainings) and the clinical role of buprenorphine in medication assisted therapy (9 trainings). No training covered all 10 topics assessed. Seven programs included content on prescribing barriers, but of those, only two briefly addressed buprenorphine dispensing barriers, and none addressed the widespread belief that the Drug Enforcement Administration sets limits on the amount of buprenorphine that can be ordered and stocked. A majority of the programs (75%) addressed the clinical details of treatment, but only five addressed social barriers, such as stigma. CONCLUSION: Future trainings should develop and increase pharmacists' awareness of content to address the gaps identified in this study so they can supplement existing trainings, especially related to DEA and wholesaler regulations and thresholds, communication, stigma, and ways of overcoming these. Elsevier 2022-06-24 /pmc/articles/PMC9256820/ /pubmed/35813287 http://dx.doi.org/10.1016/j.rcsop.2022.100154 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Davis, Scott A.
Dryer, Robyn
Zule, William
Ostrach, Bayla
Carpenter, Delesha M.
A content review of buprenorphine training programs for pharmacists
title A content review of buprenorphine training programs for pharmacists
title_full A content review of buprenorphine training programs for pharmacists
title_fullStr A content review of buprenorphine training programs for pharmacists
title_full_unstemmed A content review of buprenorphine training programs for pharmacists
title_short A content review of buprenorphine training programs for pharmacists
title_sort content review of buprenorphine training programs for pharmacists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256820/
https://www.ncbi.nlm.nih.gov/pubmed/35813287
http://dx.doi.org/10.1016/j.rcsop.2022.100154
work_keys_str_mv AT davisscotta acontentreviewofbuprenorphinetrainingprogramsforpharmacists
AT dryerrobyn acontentreviewofbuprenorphinetrainingprogramsforpharmacists
AT zulewilliam acontentreviewofbuprenorphinetrainingprogramsforpharmacists
AT ostrachbayla acontentreviewofbuprenorphinetrainingprogramsforpharmacists
AT carpenterdelesham acontentreviewofbuprenorphinetrainingprogramsforpharmacists
AT davisscotta contentreviewofbuprenorphinetrainingprogramsforpharmacists
AT dryerrobyn contentreviewofbuprenorphinetrainingprogramsforpharmacists
AT zulewilliam contentreviewofbuprenorphinetrainingprogramsforpharmacists
AT ostrachbayla contentreviewofbuprenorphinetrainingprogramsforpharmacists
AT carpenterdelesham contentreviewofbuprenorphinetrainingprogramsforpharmacists